As of Jul 22
| +0.18 / +0.24%|
The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 78.00, with a high estimate of 100.00 and a low estimate of 48.00. The median estimate represents a +3.07% increase from the last price of 75.68.
The current consensus among 26 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.